REGENXBIO's (RGNX) CEO Ken Mills on Q3 2017 Results - Earnings Call Transcript

11/9/17

REGENXBIO Inc. (NASDAQ:RGNX)

Q3 2017 Earnings Conference Call

November 8, 2017 4:30 PM ET

Executives

Patrick Christmas – General Counsel

Ken Mills – President and Chief Executive Officer

Vit Vasista – Chief Financial Officer

Analysts

Gbolahan Amusa – Chardon

Bin Lu – Raymond James

Josh Schimmer – Evercore ISI

Ying Huang – Bank of America Merrill Lynch

Operator

Good day, ladies and gentlemen, and welcome to the REGENXBIO Third Quarter 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]

I would now like to turn the conference over to Patrick Christmas, General Counsel. You may begin.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.